Kim Kardashian's Prescription Drug Promotion Post Angers the FDA

Share
Tweet
Pin It
Share
Tweet
Pin It
When Kim Kardashian talks, people listen - and that's exactly why the FDA is not happy with her right now.

Last month, the reality star took to her various social media sites to share a photo of herself holding a bottle of Diclegis, a morning sickness pill and gushed about how much it has been helping her conquer the nausea. "OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, but nothing helped, so I talked to my doctor. He prescribed me #Diclegis, and I felt a lot better and most importantly, it's been studied and there was no increased risk to the baby," she wrote, in the now-deleted post which was screengrabbed by Forbes.

She then said she loves the medicine so much, she's partnering with the company that makes it to raise awareness about morning sickness.

Unfortunately, she also raised awareness to the people in the FDA office about the fact that she was promoting the drug without also disclosing the risks. According to TMZ, the FDA fired off a letter to the company that makes the drug telling them to either stop "misbranding" the drug or take it off the market. They also demanded that they correct the problem by getting Kim to repost her endorsements with the proper warnings.

Only problem is that she apparently only had a one-post deal with them, but since she's deleted the original post, maybe she'll post a new one with the additional info?
Want More? Like us on Facebook

MORE CELEB SCOOPS

Show Comments
Join Our Newsletter
Stay fetch. Sign up for The Cray, our daily roundup of all things buzzworthy. From Kylie Jenner's trendsetting style (btw, puberty goals AF) to life-changing tech news (tweeting an emoji to order a pizza #YES), The Cray is all you need to impress the squad.
Privacy Terms